share_log

DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call

DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call

DaVita Inc. 計劃2024年第一季度投資者電話會議
德維特 ·  04/17 00:00

DENVER, April 17, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.

丹佛,2024 年 4 月 17 日/PRNewswire/— DaVita Inc.(紐約證券交易所代碼:DVA)今天宣佈,將於美國東部時間2024年5月2日星期四下午5點舉行季度電話會議,討論第一季度業績。該公司計劃在當天收盤後發佈業績。

This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:

本次電話會議也正在進行網絡直播,可以在DaVita IR網頁上觀看。您可以按如下方式加入此次通話:

Thursday, May 2, 2024
Starting at 5:00 p.m. EDT
Webcast can be accessed using this link
Dial in number: 877-918-6630
International dial in: 517-308-9042

2024 年 5 月 2 日,星期四
從美國東部時間下午 5:00 開始
可以使用此訪問網絡直播 鏈接
撥入號碼:877-918-6630
國際撥號:517-308-9042

When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.

致電時,請向接線員提供 “收入” 密碼,並提供您的姓名和公司隸屬關係。無法收聽電話會議的投資者將能夠通過我們的網站investors.davita.com觀看重播。不會有電話重播。

About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of December 31, 2023, DaVita served approximately 250,200 patients at 3,042 outpatient dialysis centers, of which 2,675 centers were located in the United States and 367 centers were located in 11 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

關於 DaVita Inc.
DaVita(紐約證券交易所代碼:DVA)是一家醫療保健提供商,專注於改變醫療服務,以改善全球患者的生活質量。該公司是美國最大的腎臟護理服務提供商之一,20多年來一直是臨床質量和創新的領導者。從減緩腎臟疾病的進展到幫助支持移植,從急性住院護理到家庭透析,DaVita在各個階段爲患者提供護理,爲他們的腎臟健康之旅做好準備。截至2023年12月31日,DaVita在3,042個門診透析中心爲約250,200名患者提供服務,其中2675箇中心位於美國,367箇中心位於全球其他11個國家。DaVita減少了住院人數,提高了死亡率,並共同推動腎臟護理行業爲世界各地的所有患者採用公平和高質量的護理標準。要了解更多信息,請訪問 davita.com/關於

Contact Information
Investors:
IR@davita.com

聯繫信息
投資者:
IR@davita.com

DaVita Logo (PRNewsfoto/DaVita)

SOURCE DaVita

來源 DaVita

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論